Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
124 I-Nal PET/CT Based 3-D radiobiological dosimetry (3D-RD) for 131I-Nal therapy of metastatic well-differentiated thyroid cancer. MedStar authors:
- Atkins, Frank
- Khorjekar, Gauri
- Orquiza, Michael D
- Van Nostrand, Douglas
Year: 2013
Department: - Department of Medicine/Nuclear Medicine
All authors: - Senthamizhchelvan S, Hobbs R, Atkins F, Khorjekar G, Orquiza M, Van Nostrand D, Sgouros G
|
|
14.
|
|
|
15.
|
|
|
16.
|
|
|
17.
|
|
|
18.
|
|
|
19.
|
|
|
20.
|
How should one measure and how low should the urinary iodine excretion be prior to radioiodine imaging and/or therapy in patients with differentiated thyroid cancer? An educational exhibit MedStar authors:
- Bethancourt, E
- Burman, Kenneth D
- Moreau, Shari
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2015
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Bethancourt E, Moreau S, Guan H, Burman K, Wartofsky L, Van Nostrand D
|
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
|
|
28.
|
The utility of 18F sodium fluoride PET bone scans in patients suspected of metastatic skeletal disease secondary to differentiated thyroid cancer MedStar authors:
- Bethancourt, E
- Burman, Kenneth D
- Garcia, Carlos
- Van Nostrand, Douglas
- Wartofsky, Leonard
- Wexler, Jason
Year: 2015
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Garcia CA, Van Nostrand D, Wexler JA, Bethancourt E, Burman k, Wartofsky l
|
|
29.
|
|
|
30.
|
Effects of dosimetry-guided 131I therapy for metastatic differentiated thyroid cancer on complete blood counts MedStar authors:
- Bikas, A
- Burman, Kenneth D
- Desale, Sameer
- Mete, Mihriye
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2015
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Bikas A, Burman K, Desale S., Mete M, Wartofsky L, Van Nostrand D
|
|
31.
|
Poor compliance for continuous sialogogues in patient-reported surveys. MedStar authors:
- Burman, Kenneth D
- Kulkarni, Kanchan P
- Moreau, Shari
- Van Nostrand, Douglas
- Wartofsky, Leonard
- Wu, Di
Year: 2018
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors:
- Burman K
- Kharazi P
- Khorjekar G
- Kulkarni K
- Moreau S
- Van Nostrand D.
- Wartofsky L
- Wu D
|
|
32.
|
The frequency and content of documents issued for patients' 131I therapies for security agents: the final report of a national survey MedStar authors:
- Bethancourt, E
- Bikas, A
- Burman, Kenneth D
- Orquiza, Michael H
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2015
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Bethancourt E, Van Nostrand D, Orquiza M, Bloom G, Bikas A, Burman k, Wartofsky l
|
|
33.
|
The public sites and frequency of detection of patients treated with 131I and the security management of those patients: the final report of a national survey MedStar authors:
- Bethancourt, E
- Bikas, A
- Burman, Kenneth D
- Orquiza, Michael H
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2015
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Bethancourt E, Van Nostrand D, Orquiza M, Bloom G, Bikas A, Burman k, Wartofsky l
|
|
34.
|
Radioiodine dosimetry practices in the united states for differentiated thyroid cancer: preliminary report. MedStar authors:
- Burman, Kenneth D
- Gomes Lima, Christiane J
- Van Nostrand, Douglas
- Wartofsky, Leonard
- Wu, Di
- Ylli, Dorina
Year: 2019
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
- Pathology
All authors: - Wu D...[Ylli D, Gomes-Lima C, Burman K, Wartofsky L, Van Nostrand], et al.
|
|
35.
|
New use for an old isotope. MedStar authors:
- Burman, Kenneth D
- Gomes Lima, Christiane J
- Van Nostrand, Douglas
- Wartofsky, Leonard
- Wu, Di
- Ylli, Dorina
Year: 2018
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors:
- Burman K
- Gomes Lima C
- Van Nostrand D.
- Wartofsky L
- Wu D
- Ylli D
|
|
36.
|
|
|
37.
|
Assessment of serial comprehensive metabolic Panel ats following dosimetry-guided 131I treatment for metastatic differentiated thyroid cancer MedStar authors:
- Bikas, Athanasios
- Boulougoura, Afroditi
- Burman, Kenneth D
- Mirza, Faryal
- Vachhani, Shivangi
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2016
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Bikas A, Boulougoura A, Mirza F, Vachhani S, Wartofsky L, Van Nostrand D, Burman K
|
|
38.
|
Assessment of serial complete blood counts following dosimetry-guided 131I treatment for metastatic differentiated thyroid cancer MedStar authors:
- Bikas, A
- Boyle, Lisa M
- Burman, Kenneth D
- Desale, Sameer
- Mete, Mihriye
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2015
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Bikas A, Burman K, Desale S, Mete M, Boyle L, Wartofsky L, Van Nostrand D
|
|
39.
|
|
|
40.
|
|
|
41.
|
Survival rate in differentiated thyroid cancer patients with bone metastases. MedStar authors:
- Atkins, Francis
- Burman, Kenneth D
- Khorjekar, Gauri R
- Kulkarni, Kanchan
- Moreau, Shari
- Orquiza, Michael H
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2014
Department:
- Medicine/Endocrinology
- Medicine/General Internal Medicine
- Medicine/Nuclear Medicine
All authors: - Orquiza M, Van Nostrand D, Khorjekar G, Moreau S, Atkins F, Kulkarni K, Burman KD, Wartofsky L
|
|
42.
|
Epiphora and xerophthalmia after 131I therapy: the frequency, time of onset, severity, and duration. MedStar authors:
- Acio, Elmo
- Burman, Kenneth D
- Garcia, Carlos
- Khorjekar, Gauri R
- Kulkarni, Kanchan
- Orquiza, Michael H
- Schneider, M
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2014
Department:
- Medicine/Endocrinology
- Medicine/General Internal Medicine
- Medicine/Nuclear Medicine
All authors: - Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L, Van Nostrand D
|
|
43.
|
|
|
44.
|
Altered taste after 131I therapy: the frequency, time of onset, severity, and duration MedStar authors:
- Acio, Elmo
- Burman, Kenneth D
- Garcia, Carlos
- Khorjekar, Gauri R
- Kulkarni, Kanchan
- Orquiza, Michael H
- Schneider, M
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2014
Department:
- Medicine/Endocrinology
- Medicine/General Internal Medicine
- Medicine/Nuclear Medicine
All authors: - Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L,Van Nostrand D
|
|
45.
|
Brain metastases from differentiated thyroid carcinoma: current therapies and outcomes. MedStar authors:
- Burman, Kenneth D
- Deeb, Hala
- Gomes-Lima, Christiane J
- Hritani, Rama
- Mete, Mihriye
- Punukollu, Sree
- Rao, Sarika
- Van Nostrand, Douglas
- Wu, Di
- Zeymo, Alexander
Year: 2017
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors:
- Burman K
- Deeb H
- Gomes-Lima C
- Hritani R
- Jonklaas J
- Mete M
- Punukollu S
- Rao S
- Van Nostrand D
- Wu D
- Zeymo A
|
|
46.
|
Prevalence and survival analysis of patients with brain metastases from differentiated thyroid carcinoma in MedStar institutions. MedStar authors:
- Aulisi, Edward
- Burman, Kenneth D
- Deeb, Hala
- Gomes Lima, Christiane J
- Hritani, Rama
- Mete, Mihriye
- Punukollu, Sree
- Rao, Sarika
- Van Nostrand, Douglas
- Wu, Di
- Zeymo, Alexander
Year: 2018
Department:
- Medicine/Endocrinology
- Surgery/Neurosurgery
All authors:
- Aulisi E
- Burman K.
- Deeb H
- Gomes-Lima C
- Hritani R
- Jonklaas J
- Mete M
- Punukollu S
- Rao S
- Van Nostrand D
- Wu D
- Zeymo A
|